Number of Shares
325,000.00
Current Holdings Value*
$19.82 Mil
% of Portfolio
2.28%
Total Estimate Gain
$245,199.49
% of Total Estimate Gain
0.40%

Rhenman & Partners Asset Management AB's Bristol-Myers Squibb Co Holding Summary

As of 2025-03-31, Rhenman & Partners Asset Management AB held 325,000.00 shares of Bristol-Myers Squibb Co(BMY), totaling $19.82 Mil. This investment constitutes 2.28% of their stock portfolio, and Rhenman & Partners Asset Management AB now holds 0.02% of the outstanding Bristol-Myers Squibb Co(BMY) stock.

The initial trade took place in 2014Q1. And since then Rhenman & Partners Asset Management AB has made 13 purchases of BMY, at an average price of $55.38, for a total of 1.10 Mil shares. In addition, there have been 10 sales at an average price of $59.08 for 771,815.00 shares. Based on historical transaction data and BMY's current price of $47.36, Rhenman & Partners Asset Management AB's estimated gain on his BMY holdings is $245,199.49, reflecting a 0.40% gain to date.

Rhenman & Partners Asset Management AB BMY ($47.36) Holding Chart

Rhenman & Partners Asset Management AB BMY ($47.36) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1